Veradermics, Inc SEC filings MANE

Veradermics, Inc has 97 filings in SEC EDGAR's recent list, going back to Oct 9, 2020. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Form Description Filed Period
8-K Current report
Regulation FD disclosure, Other events
 Oct 19, 2026 Oct 19, 2026
8-K Current report
Results of operations
 Aug 11, 2026 Aug 11, 2026
8-K Current report
Regulation FD disclosure, Other events
 Jul 15, 2026 Jul 15, 2026
8-K Current report
Results of operations
 May 12, 2026 May 12, 2026
8-K Current report
Material agreement, Unregistered share sale
 May 1, 2026 May 1, 2026
8-K Current report
Results of operations
 Apr 27, 2026 Apr 27, 2026
8-K Current report
Regulation FD disclosure, Other events
 Apr 27, 2026 Apr 27, 2026
8-K Current report
Results of operations
 Mar 30, 2026 Mar 30, 2026
8-K Current report
Bylaw or fiscal year change
 Feb 5, 2026 Feb 5, 2026

Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
MANE (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New Haven, CT
SEC filer status
, Emerging growth company
SEC CIK
1827635

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.